Pharmagest Group announced that Dominique PAUTRAT will be stepping down as Chief Executive Officer of the company, to become Chairman of the Executive Board of La Coop?rative WELCOOP as of April 22, 2022. He will continue to serve as a director on the company?s board of directors. On 3 December 2021, the following appointments were proposed to the Board of Directors by its Chairman, Mr. Thierry CHAPUSOT: Denis SUPPLISSON, current Deputy CEO and Manager of the Europe Pharmacy Solutions Division will become the Pharmagest Group?s Chief Executive Officer, replacing Dominique PAUTRAT, with effect from 22 April 2022. These proposed appointments will be submitted to the vote of the Board of Directors of the Pharmagest Group, which will meet for this purpose in March 2022. Denis SUPPLISSON began his career in 1991 at Pharmagest Inter@ctive as Technology Manager, and subsequently Customer Service Manager for France?s Centre Region. In 2002, he joined the company?s headquarters team to develop the Customer Service department at the national level. In 2005, following the absorption of CIP by Pharmagest Inter@ctive, he left Nancy for Lorient where he contributed to the merger of the Group's methods and processes. After returning to the head office in Nancy in 2009, Denis SUPPLISSON became the Manager of the France Pharmacy Business Unit and was appointed manager of the Europe Pharmacy Solutions Division in January 2010. In that same year, he was appointed Deputy CEO of Pharmagest Group and became a member of the Board of Directors in 2013. In April 2022, he will assume the functions of Pharmagest Group?s CEO.